Status:
COMPLETED
Oral Administration of AlequelTM for Patients With Inflammatory Bowel Disease (IBD)
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Crohn's Disease
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
Oral administration of Alequel, a mixture of proteins derived from the patient's bowel will be tested in patients with inflammatory bowel disease.
Detailed Description
Oral administration of Alequel prepared from patients biopsies will be tested in patients with inflammatory bowel disease to determine its anti inflammatory effect.
Eligibility Criteria
Inclusion
- Crohn's disease
Exclusion
- Immune suppression
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT02185183
Start Date
January 1 2008
End Date
January 1 2010
Last Update
October 1 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.